Comparing GLP-1 Receptor Agonists with SGLT2 Inhibitors for Type 2 Diabetes Patients
Investigators from Saint Louis University discuss their recent study comparing GLP-1 receptor agonists with SGLT2 inhibitors.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.